Introducing Credence Colorectal

Credence Breast and Credence Colorectal are the two gene panels designed for predisposition screening. Credence Comprehensive Breast Cancer Panel (Credence Breast) enables simultaneous testing of the commonest breast cancer predisposition genes including the most famous markers BRCA1 and BRCA2. Credence Comprehensive Colorectal Panel (Credence ColoRectal) sequences 17 genes, for testing of the commonest colorectal cancer predisposition.

How does genetic predisposition testing help?

Genetic predispositions or genetic susceptibility increases the likelihood in a person of developing a genetically inherited disease, depending on his or her genetic makeup.  These genetic changes contribute to the development of a disease but do not directly cause it. Genetic predisposition testing therefore helps in evaluating a person’s risk for developing a genetic based disease or for passing a genetic disease on to their offspring. This knowledge may guide the decisions an individual and his or her doctor make about your health care, including possible treatment options, additional testing and screening or family planning. Using this genetic information, the doctors can work with their patients proactively to help them make choices that may lead to healthier lives.

Once detected, the information generated by the test can help the individuals and their families take preventive measures to lead a healthier, symptom free long life.

101738585

Credence ColoRectal Screening panel

Credence ColoRectal Screening panel simultaneously screens 17 genes that are responsible for inherited predisposition to ColoRectal Cancer.  The genes covered in the panel include;

APC, ATM, AXIN2, BMPR1A, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, SMAD4, STK11, TP53 and XRCC2.

Key points

  • Test whether you are genetically predisposed towards colorectal cancer
  • Credence testing panel covers 17 different genes responsible for colorectal cancer
  • Comprehensive testing with 99.7% accuracy
  • Best possible action plans if predisposed towards colorectal cancer
  • Benefit from early diagnosis, reduced medical costs and peace of mind

Did you know?

Some carry a life-time fear of acquiring major genetic conditions like cancer or heart conditions from the very moment a first degree relative is identified with similar diseases.